March 17, 2015 by Brad Perriello
Medtronic got in on a $16.5 million Series B round for Glooko and its diabetes management platform, joining fellow new investor Canaan Partners and existing backers The Social + Capital Partnership and Samsung.
Palo Alto, Calif.-based Glooko’s platform is designed to link more than 30 blood glucose testing systems with Apple’s iPhone or Google’s Android smartphones. Data from the glucometers is then sent to Glooko’s cloud-based Population Tracker, where healthcare providers receive a “simple-to-interpret, risk-stratified” view, the Palo Alto, Calif.-based company said. Read more
March 16, 2015 by Mark Hollmer
Boston startup Pegasus Therapeutics is using crowdfunding site Indiegogo to solicit money for the development of a stent-like device designed to treat pediatric patients with coronary artery aneurysms.
The company seeks to raise an initial $50,000 to develop a “benchtop flow model” of the arterial system and the heart, complete with simulated aneurysms. Having that will allow testing and refinements of current Pegasus prototypes, according to the company’s Indiegogo page. It has a broader goal of raising $300,000, which it said will back a final design, generate early test data and support development of an assembly process for eventual manufacturing. Read more
March 19, 2015 by Brad Perriello
Svelte Medical Systems today said it plans to use the $16 million it just raised to commercialize its wrist-delivered stenting technology.
New Providence, N.J.-based Svelte said the round involved current investors and was led by CNF Investments, the West Health Investment Fund and New Science Ventures. Read more